LY6E

lymphocyte antigen 6 family member E, the group of LY6/PLAUR domain containing

Basic information

Region (hg38): 8:143017982-143023832

Links

ENSG00000160932NCBI:4061OMIM:601384HGNC:6727Uniprot:Q16553AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the LY6E gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the LY6E gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
missense
11
clinvar
2
clinvar
1
clinvar
14
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 11 2 3

Variants in LY6E

This is a list of pathogenic ClinVar variants found in the LY6E region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
8-143021314-C-T not specified Uncertain significance (Jul 09, 2024)3541311
8-143021320-C-T not specified Uncertain significance (Jun 29, 2023)2608347
8-143021327-G-T not specified Uncertain significance (Jan 09, 2025)3869111
8-143021406-G-A not specified Uncertain significance (Aug 26, 2024)2363497
8-143021602-C-G not specified Uncertain significance (Aug 04, 2024)3541312
8-143021634-G-A not specified Likely benign (Jan 18, 2023)3121612
8-143021655-A-T not specified Uncertain significance (Sep 16, 2021)2378393
8-143021665-G-C not specified Uncertain significance (May 10, 2023)2535556
8-143021695-G-A not specified Uncertain significance (Nov 11, 2024)3541313
8-143021699-G-A Benign (Mar 30, 2018)782281
8-143021703-G-A Likely benign (Jun 05, 2018)711022
8-143021705-T-G not specified Uncertain significance (Mar 20, 2023)2527177
8-143021708-C-T Benign (Mar 29, 2018)788736
8-143021715-C-T not specified Uncertain significance (Dec 03, 2021)2264557
8-143021718-G-C not specified Uncertain significance (Mar 20, 2023)2527178
8-143021724-G-A Benign (Mar 30, 2018)782282
8-143021764-C-T not specified Uncertain significance (Aug 09, 2021)2336211

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
LY6Eprotein_codingprotein_codingENST00000520466 35851
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.3210.618125702041257060.0000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5746781.60.8210.00000500835
Missense in Polyphen2024.6220.81229273
Synonymous-0.1644240.71.030.00000276288
Loss of Function1.4514.210.2382.62e-742

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002890.0000289
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00002650.0000264
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in T-cell development. Believed to act as a modulator of nicotinic acetylcholine receptors (nAChRs) activity. In vitro inhibits alpha-3:beta-4-containing nAChRs maximum response. {ECO:0000250|UniProtKB:Q64253}.;
Pathway
Ectoderm Differentiation;Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins (Consensus)

Recessive Scores

pRec
0.189

Intolerance Scores

loftool
0.267
rvis_EVS
0.15
rvis_percentile_EVS
64.32

Haploinsufficiency Scores

pHI
0.187
hipred
N
hipred_score
0.210
ghis
0.399

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.363

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ly6e
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); homeostasis/metabolism phenotype; muscle phenotype; endocrine/exocrine gland phenotype;

Gene ontology

Biological process
cell surface receptor signaling pathway;negative regulation of signaling receptor activity
Cellular component
extracellular region;plasma membrane;membrane;anchored component of membrane
Molecular function
acetylcholine receptor inhibitor activity